
Ketek: FDA Managers Value Drug Maker Relations Over Patient Safety
U.S. Food and Drug Administration officials ignored safety concerns raised by their own experts and hid evidence of clinical trial fraud when they approved the antibiotic Ketek(telithromycin) for streptococcus pneumonia in 2004.